Research Articles Library
Literature Analysis Tools
Advanced Search
Filter by PMID, year, source, DOI and other criteria
Literature Analysis
Analyze research trends and hotspots
Batch Export
Export search results to Excel/PDF
Predicting Adverse Events to Thiopurines in IBD: Are We a Step Closer?
Publication Year: 2024 Source: Inflamm Bowel Dis PMID: 39011862 DOI: 10.1093/ibd/izae125
Thiopurines remain an important option in the treatment of IBD. However, the unpredictable and sometimes serious side effects and intolerance remain a major challenge. Pretreatment of extended genetic panel analysis, identification of novel variants, and monitoring of intermediate metabolites will help improve the overall outcome and reduce the toxicity.
Correction to: Supplementation With Oral vs Intravenous Iron for Anemia With IBD or Gastrointestinal Bleeding: Is Oral Iron Getting a Bad Rap?
Publication Year: 2024 Source: Am J Gastroenterol PMID: 39012009 DOI: 10.14309/ajg.0000000000002913
No Abstract
A Systematic Overview of Contraindications and Special Warnings for Biologic and Targeted Synthetic Disease Modifying Antirheumatic Drugs: Establishing a Framework to Create a "Safety Checklist"
Publication Year: 2024 Source: Drug Saf PMID: 39012469
No Abstract
Micronutrient deficiencies in inflammatory bowel disease: an incidence analysis
Publication Year: 2024 Source: Eur J Gastroenterol Hepatol PMID: 39012640 DOI: 10.1097/MEG.0000000000002821
BACKGROUND: Micronutrient deficiencies associated with malnutrition in patients with inflammatory bowel disease (IBD) can lead to complications including anemia, coagulopathy, poor wound healing, and colorectal cancer. This study aimed to investigate micronutrient deficiencies (copper, vitamins A, B 9 , E, and K) in IBD patients and highlight associated symptoms to …
[The role of bile acids in the therapy of selected diseases]
Publication Year: 2024 Source: Postepy Biochem PMID: 39012695
No Abstract
Correction: Effects of structured exercise programmes on physiological and psychological outcomes in adults with inflammatory bowel disease (IBD): A systematic review and meta-analysis
Publication Year: 2024 Source: PLoS One PMID: 39012902 DOI: 10.1371/journal.pone.0307509
[This corrects the article DOI: 10.1371/journal.pone.0278480.].
Mitochondrial perturbation in the intestine causes microbiota-dependent injury and gene signatures discriminative of inflammatory disease
Publication Year: 2024 Source: Cell Host Microbe PMID: 39013472 DOI: 10.1016/j.chom.2024.06.013
Mitochondrial dysfunction is associated with inflammatory bowel diseases (IBDs). To understand how microbial-metabolic circuits contribute to intestinal injury, we disrupt mitochondrial function in the epithelium by deleting the mitochondrial chaperone, heat shock protein 60 (Hsp60(Delta/DeltaIEC)). This metabolic perturbation causes self-resolving tissue injury. Regeneration is disrupted in the absence of the …
Prospective therapeutic targets and recent advancements in the treatment of inflammatory bowel disease
Publication Year: 2024 Source: Immunopharmacol Immunotoxicol PMID: 39013809 DOI: 10.1080/08923973.2024.2381756
OBJECTIVE: Inflammatory Bowel Disease (IBD) poses a persistent challenge in the realm of gastroenterology, necessitating continual exploration of innovative treatment strategies. The limited efficacy and potential side effects associated with existing therapeutic modalities underscore the urgent need for novel approaches in IBD management. This study aims to examine potential therapeutic …
Causality of genetically determined blood metabolites on inflammatory bowel disease: a two-sample Mendelian randomization study
Publication Year: 2024 Source: Sci Rep PMID: 39014047 DOI: 10.1038/s41598-024-67376-0
Inflammatory bowel disease (IBD) is a chronic and recurrent inflammatory disease of the gastrointestinal tract, including two subtypes: Crohn's disease (CD) and ulcerative colitis (UC). Metabolic disorders are important factors in the development of IBD. However, the evidence for the causal relationship between blood metabolites and IBD remains limited. A …
MYO5B gene mutations may promote the occurrence of very early onset inflammatory bowel disease: a case report
Publication Year: 2024 Source: BMC Med Genomics PMID: 39014344 DOI: 10.1186/s12920-024-01962-z
BACKGROUND: With recent advances in gene sequencing technology, more than 60 genetic mutations associated with very early onset inflammatory bowel disease (VEO-IBD) have been reported. Most of the genes are associated with immune deficiencies. The Myosin 5B (MYO5B) gene is primarily involved in cell motility and material transport which is …
Need more literature?
The current database contains 98453 research articles. If you need to search for more literature or perform AI analysis, please use our knowledge acquisition module or explore external literature resources.
External Resources: Access comprehensive literature databases worldwide